6533b7dcfe1ef96bd127279e

RESEARCH PRODUCT

Clinical utility of plasma-based digital next-generation sequencing (NGS) in patients with advance-stage lung adenocarcinomas with insufficient tumor samples for tissue genotyping.

Oscar Juan VidalJavier De CastroEnriqueta FelipReyes Bernabe CaroInmaculada Ramos GarciaPilar Garrido LopezEloisa Jantus-lewintreRichard B. LanmanIris FaullRosario Garcia CampeloCarlos CampsLuis Paz-aresJose Miguel Sanchez TorresJose Manuel Trigo PerezMariano Provencio-pullaJon ZugazagoitiaSantiago Ponce AixMagda PalkaAna Gómez RuedaDolores Isla

subject

OncologyCancer Researchmedicine.medical_specialtyLungbusiness.industryDNA sequencingSubtypingInsufficient Tissuemedicine.anatomical_structureOncologyInternal medicineMedicineIn patientStage (cooking)businessGenotyping

description

9101Background: Approximately 20 % of tumor biopsies from patients with advanced-stage lung adenocarcinomas yield insufficient tissue for successful molecular subtyping. In this study, we have anal...

https://doi.org/10.1200/jco.2018.36.15_suppl.9101